In 1999, I got a call from a friend who asked if he could put me in touch with a pharmaceutical company in Europe that was seeking expansion to North America. It did not take much convincing for me to rise to the challenge - without much expertise in the field, I should mention. Armed only with the skills I gained from working in the industrial chemicals sector, and a steadfast belief in the quality of the API that the company was producing, I helped broker an important deal that is actually still in effect to this day.
It wasn’t easy.
There were many moments in the 5 years of development and negotiation when we were convinced that the deal would never see the light of day. But my associates and I persisted, and after our success in obtaining our first FDA approval in 2004, I decided to dedicate my time to developing pharma projects on a global scale.
Since then, my team and I have been working to develop new markets, to bring new technologies to fruition, and to help deliver the latest medicines and treatments to the people who need them most.
M3 Global has established itself as a trusted business partner for many, helping them to market, distribute or to develop their product - whether in pharma, oncological technology, healthcare, or biotech.
Our company prides itself on placing integrity and ethics above all else and we hope to keep building lasting and meaningful partnerships with both individuals and companies all over the world.
-Sergio Moskovitz, Founder & CEO
